Hexima’s Chief Science Officer, Professor Marilyn Anderson, Onychomycosis Project Leader, Dr Michael Baker and Researcher, Dr Brigitte Hayes, have presented Hexima’s human antifungal technology at ASM Microbe 2016. The conference is an opportunity to showcase the benefits of Hexima’s technology and our progress towards clinical trials for fungal nail infections (onychomycosis). PhD Student Kathy Parisi also presented work relating to Hexima’s antifungal technology.
All three posters were met with an enthusiastic reception and generated significant interest among conference delegates.
Copies of the posters can be found below: